For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: George Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com

Daiichi Sankyo Announces New Chairman and President

Tokyo, Japan (January 31, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the following new assignments of representative directors which were resolved at the board of directors meeting held on January 31, 2017.

 

Effective date: April 1, 2017

Purpose: Strengthen Daiichi Sankyo’s management setup to achieve the goals of the fourth mid-term management plan towards the realization of the Company’s 2025 Vision of being a Global Pharma Innovator with Competitive Advantage in Oncology, which was publicly announced in March 2016.

 

Name	Current Position	New Position
George Nakayama	Representative Director, President and CEO	Representative Director, Chairman and CEO
Sunao Manabe	Representative Director, Member of the Board, Executive Vice President,	Representative Director, Member of the Board, President and COO
Kazunori Hirokawa	Representative Director, Member of the Board, Executive Vice President,	Representative Director, Member of the Board, Executive Vice President and CFO

 

Curriculum Vitae

 

George Nakayama

Born: May 11, 1950

New Positions Held:  Representative Director, Chairman and CEO

 

Career Summary

Mar. 1976         Graduated from Department of Biological Engineering, Graduate School of Osaka University

Mar. 1979         Obtained MBA from Northwestern University, USA

Apr. 1979         Joined Suntory Holdings, Ltd.

Mar. 2000         Member of the Board, Suntory Holdings, Ltd.

Mar. 2000         President of Suntory Biomedical Research Ltd.

Dec. 2002         President and CEO of Daiichi Suntory Pharma Co., Ltd., a subsidiary company of Daiichi Pharmaceutical Co., Ltd.

Mar. 2003         Retired as Member of the Board. Suntory Holdings, Ltd.

Jun. 2003          Member of the Board, Daiichi Pharmaceutical Co., Ltd.

Jun. 2006          Director and General Manager in charge of Corporate Planning for Daiichi Pharmaceutical Co., Ltd.

Apr. 2007          Corporate Officer and General Manager in charge of Europe and the United States for Daiichi Sankyo Co., Ltd.

Apr. 2009              Executive Officer and General Manager in charge of International Markets for Daiichi Sankyo Co., Ltd.

Apr. 2010          Executive Vice President and President of Japan Company

Jun. 2010          Representative Director, President and CEO, President of Japan Company

Apr. 2014          Representative Director, President and CEO

 

 

Sunao Manabe

Born: August 5, 1954

New Positions Held: Representative Director, Member of the Board, President and COO

 

Career Summary

Mar. 1977         Graduated from Faculty of Agriculture, University of Tokyo

Apr. 1978          Joined Sankyo Co., Ltd.

Jul. 2005           Vice President of Medicinal Safety Research Laboratories, Sankyo Co., Ltd.

Apr. 2007          Vice President of Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.

Apr. 2009          Corporate Officer, Vice President of Global Project Management Department

Apr. 2011          Corporate Officer, Head of Group HR & CSR

Apr. 2012          Corporate Officer, Vice President of Corporate Strategy Department

Apr. 2014          Executive Officer, President of Japan Company and Head of Business Intelligence Division

Jun. 2014          Member of the Board, Executive Officer, President of Japan Company and Head of Business Intelligence Division

Apr. 2015          Member of the Board, Senior Executive Officer, and In charge of Global Sale & Marketing

Apr. 2016          Member of the Board, Executive Vice President, Head of General Affairs and Human Resources Division and Head of Medical Affairs Division

Jun. 2016          Representative Director, Member of the Board, Executive Vice President, Head of General Affairs and Human Resources Division and Head of Medical Affairs Division

 

 

Kazunori Hirokawa

Born: June 7, 1951

New Positions Held: Representative Director, Member of the Board, Executive Vice President and CFO

 

Career Summary

Mar. 1975         Graduated from Faculty of Pharmaceutical Sciences, University of Tokyo

Apr. 1975          Joined Daiichi Pharmaceutical Co., Ltd.

Mar. 1985         Graduated from School of Medicine, Tokyo Medical and Dental University

Oct. 2000          General Manager, Drug Safety Administration Department, Daiichi Pharmaceutical Co., Ltd.

Oct. 2002          General Manager, Medical Planning & Coordination Department

Jun. 2003          Member of the Board, General Manager, Medical Planning & Coordination         Department

Oct. 2004          Member of the Board, General Manager, R&D Strategy Department

Jun. 2005          Senior Corporate Officer, General Manager, R&D Strategy Department

Apr. 2006          Executive Vice President, Daiichi Sankyo Inc. in U.S.

Apr. 2007          Executive Officer, Head of R&D Division, Daiichi Sankyo Co., Ltd.

Apr. 2010          Senior Executive Officer, Head of R&D Division

Jun. 2010          Member of the Board, Senior Executive Officer, Head of R&D Division

Apr. 2012          Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division

Apr. 2013          Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division and Head of Business Intelligence Division, Japan Company

Apr. 2014          Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division

Apr. 2015          Member of the Board, Executive Vice President, Head of Corporate Management Division

Jun. 2015          Representative Director, Member of the Board, Executive Vice President, Head of Corporate Management Division